Tyra Biosciences, Inc. Balance Sheet
TYRA / Health Care|5 years of annual SEC 10-K data (FY2020-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Tyra Biosciences, Inc. had $364M in total assets and $343M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | $92.0M | $58.0M | $251.2M | $302.2M | $15.2M |
| Current Assets | $347.5M | $211.7M | $257.3M | $304.1M | $15.3M |
| PP&E (Net) | $1.7M | $1.6M | $1.1M | $1.0M | $297.0K |
| Total Assets | $363.6M | $225.9M | $266.2M | $306.7M | $16.0M |
| Current Liabilities | $14.6M | $15.3M | $5.7M | $3.6M | $1.9M |
| Shareholders' Equity | $343.2M | $204.3M | $257.8M | $301.7M | -$13.6M |